JP2012510987A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510987A5 JP2012510987A5 JP2011539117A JP2011539117A JP2012510987A5 JP 2012510987 A5 JP2012510987 A5 JP 2012510987A5 JP 2011539117 A JP2011539117 A JP 2011539117A JP 2011539117 A JP2011539117 A JP 2011539117A JP 2012510987 A5 JP2012510987 A5 JP 2012510987A5
- Authority
- JP
- Japan
- Prior art keywords
- zaleplon
- dosage form
- biodegradable
- layer
- gastroretentive dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 claims 89
- 229960004010 zaleplon Drugs 0.000 claims 89
- 239000002552 dosage form Substances 0.000 claims 59
- 230000002496 gastric effect Effects 0.000 claims 18
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 11
- 229920000642 polymer Polymers 0.000 claims 10
- 239000002775 capsule Substances 0.000 claims 9
- 238000013270 controlled release Methods 0.000 claims 9
- 239000011248 coating agent Substances 0.000 claims 7
- 238000000576 coating method Methods 0.000 claims 7
- 238000000034 method Methods 0.000 claims 5
- 230000036470 plasma concentration Effects 0.000 claims 5
- 210000004051 gastric juice Anatomy 0.000 claims 3
- 239000004014 plasticizer Substances 0.000 claims 3
- 239000000843 powder Substances 0.000 claims 3
- 108010010803 Gelatin Proteins 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 238000012423 maintenance Methods 0.000 claims 2
- 230000014759 maintenance of location Effects 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 229920003169 water-soluble polymer Polymers 0.000 claims 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 229940060367 inert ingredients Drugs 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 206010022437 insomnia Diseases 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000006104 solid solution Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000003466 welding Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12005108P | 2008-12-04 | 2008-12-04 | |
| US61/120,051 | 2008-12-04 | ||
| PCT/IB2009/007731 WO2010064139A2 (en) | 2008-12-04 | 2009-10-19 | Zaleplon gastroretentive drug delivery system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014231788A Division JP6104873B2 (ja) | 2008-12-04 | 2014-11-14 | ザレプロン胃内滞留性薬剤送達システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012510987A JP2012510987A (ja) | 2012-05-17 |
| JP2012510987A5 true JP2012510987A5 (OSRAM) | 2012-12-06 |
Family
ID=42232930
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539117A Pending JP2012510987A (ja) | 2008-12-04 | 2009-10-19 | ザレプロン胃内滞留性薬剤送達システム |
| JP2014231788A Expired - Fee Related JP6104873B2 (ja) | 2008-12-04 | 2014-11-14 | ザレプロン胃内滞留性薬剤送達システム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014231788A Expired - Fee Related JP6104873B2 (ja) | 2008-12-04 | 2014-11-14 | ザレプロン胃内滞留性薬剤送達システム |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9693981B2 (OSRAM) |
| EP (1) | EP2378883B1 (OSRAM) |
| JP (2) | JP2012510987A (OSRAM) |
| KR (1) | KR20110116004A (OSRAM) |
| CN (1) | CN102300463B (OSRAM) |
| CA (1) | CA2745741A1 (OSRAM) |
| ES (1) | ES2562925T3 (OSRAM) |
| IL (1) | IL213376A (OSRAM) |
| PL (1) | PL2378883T3 (OSRAM) |
| WO (2) | WO2010064139A2 (OSRAM) |
| ZA (1) | ZA201104620B (OSRAM) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2721493C (en) | 2008-04-18 | 2017-11-28 | Intec Pharma Ltd. | Carbidopa/levodopa gastroretentive drug delivery |
| UA108211C2 (uk) * | 2009-11-04 | 2015-04-10 | Янссен Рід Айрленд | Бензімідазолімідазольні похідні |
| IN2012MN02923A (OSRAM) * | 2010-06-01 | 2015-06-05 | Rubicon Res Private Ltd | |
| US9248111B2 (en) | 2011-03-01 | 2016-02-02 | Pharnext | Therapeutic approaches for treating parkinson's disease |
| EP2796132B1 (en) * | 2011-03-01 | 2018-05-02 | Pharnext | Baclofen and acamprosate based therapy of neurological disorders |
| US9180108B2 (en) | 2011-10-27 | 2015-11-10 | Medtronic, Inc. | Baclofen formulations and methods for making same |
| US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| EP2854774A4 (en) | 2012-06-01 | 2015-11-18 | Lynn Health Science Inst Inc | METHODS OF TREATING INSOMNIA |
| WO2014039951A1 (en) * | 2012-09-10 | 2014-03-13 | Novartis Ag | Enteral pharmaceutical compositions |
| CA2914365C (en) | 2013-06-05 | 2022-03-15 | Synchroneuron, Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| WO2015038854A1 (en) | 2013-09-13 | 2015-03-19 | R.P. Scherer Technologies, Llc | Encased-pellet tablets |
| FR3014692B1 (fr) * | 2013-12-18 | 2016-01-29 | Ethypharm Sa | Compositions pharmaceutiques orales a retention gastrique. |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| DK3155024T4 (da) | 2014-06-11 | 2025-07-21 | Massachusetts Inst Technology | Opholdsstrukturer og relaterede fremgangsmåder |
| CN112972871A (zh) * | 2014-12-29 | 2021-06-18 | 波士顿科学国际有限公司 | 用于化疗药物多级释放的组合物、装置和方法 |
| US10300032B2 (en) | 2015-02-20 | 2019-05-28 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
| EP3258916A1 (en) | 2015-02-20 | 2017-12-27 | Osmotica Kereskedelmi ES Szolgaltato KFT | Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics |
| US10987328B2 (en) | 2015-02-20 | 2021-04-27 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
| US10172800B2 (en) | 2015-02-20 | 2019-01-08 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form with enhanced pharmacokinetics |
| AU2016342374B2 (en) | 2015-10-23 | 2022-08-04 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| US9849125B1 (en) | 2015-11-03 | 2017-12-26 | Banner Lifie Sciences LLC | Anti-overingestion dosage forms |
| US11992552B2 (en) | 2015-12-08 | 2024-05-28 | Lyndra Therapeutics, Inc. | Geometric configurations for gastric residence systems |
| EP3463313A4 (en) | 2016-05-27 | 2019-12-18 | Lyndra, Inc. | MATERIAL ARCHITECTURE FOR STOMACH DWELLING SYSTEMS |
| KR20190026799A (ko) * | 2016-07-11 | 2019-03-13 | 인텍 파마 리미티드 | 경구 위체류 제형 및 이의 용도 |
| AU2017336154B2 (en) | 2016-09-30 | 2023-11-09 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
| CA3060026A1 (en) * | 2017-04-18 | 2018-10-25 | Jayant Jagannath Khandare | Polymer based formulation for release of drugs and bioactives at specific git sites |
| US10335375B2 (en) | 2017-05-30 | 2019-07-02 | Patheon Softgels, Inc. | Anti-overingestion abuse deterrent compositions |
| WO2018227147A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
| US11980610B2 (en) * | 2017-10-31 | 2024-05-14 | Samyang Holdings Corporation | Oral solid dosage form composition having improved disintegration and preparation method therefor |
| EP3941445A4 (en) * | 2019-03-20 | 2023-08-02 | Lyndra Therapeutics, Inc. | CAPSULES AND CAPSULE COATINGS FOR GASOLINE DOSAGE FORMS |
| US20220192995A1 (en) * | 2019-03-20 | 2022-06-23 | Lyndra Therapeutics, Inc. | Coatings for gastric residence dosage forms |
| US10792262B1 (en) | 2019-07-29 | 2020-10-06 | Saol International Limited | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
| US11654124B2 (en) | 2019-07-29 | 2023-05-23 | Amneal Pharmaceuticals Llc | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
| WO2021138495A1 (en) * | 2019-12-30 | 2021-07-08 | Fraunhofer Usa, Inc. | Particles for multi-dose delivery |
| US11491125B1 (en) | 2021-09-29 | 2022-11-08 | Amneal Pharmaceuticals Llc | Baclofen formulations and methods of minimizing patient exposure to metabolite variations |
| AU2023209872A1 (en) * | 2022-01-19 | 2024-08-01 | Lyndra Therapeutics, Inc. | Dosage forms for gastric retention |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
| US4767627A (en) | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| JPH07179334A (ja) * | 1993-12-22 | 1995-07-18 | Sanei Touka Kk | カプセル及びカプセル剤の製造方法 |
| US5780055A (en) * | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
| US6322819B1 (en) | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
| EP1064937A1 (en) | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| US6485746B1 (en) * | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| IL133196A0 (en) * | 1999-11-29 | 2001-03-19 | Yissum Res Dev Co | Gastroretentive controlled release pharmaceutical dosage forms |
| DE10004790B4 (de) * | 2000-02-01 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung |
| AU2002355686B2 (en) | 2001-07-04 | 2007-11-29 | Sun Pharmaceutical Industries Limited | Gastric retention controlled drug delivery system |
| US20080081834A1 (en) * | 2002-07-31 | 2008-04-03 | Lippa Arnold S | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| US7985422B2 (en) * | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
| US20050038042A1 (en) * | 2002-11-15 | 2005-02-17 | Jenet Codd | Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| US20040224020A1 (en) * | 2002-12-18 | 2004-11-11 | Schoenhard Grant L. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| KR100553887B1 (ko) * | 2003-06-24 | 2006-02-24 | 삼성전자주식회사 | 수직 및 수평으로 광시야각을 갖는 영상표시용 스크린 및이를 구비하는 프로젝션 텔레비전 |
| US20050090554A1 (en) * | 2003-09-12 | 2005-04-28 | John Devane | Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists |
| EP1523981A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release formulations of venlafaxine |
| US20050244517A1 (en) | 2003-11-05 | 2005-11-03 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
| EP1535952B1 (en) * | 2003-11-28 | 2013-01-16 | Universite Louis Pasteur | Method for preparing crosslinked polyelectrolyte multilayer films |
| US20050220874A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist |
| JP4756835B2 (ja) * | 2004-07-14 | 2011-08-24 | キヤノン株式会社 | 生化学反応カートリッジ |
| US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
| CN101346073B (zh) * | 2005-12-23 | 2013-02-13 | 卡夫食品环球品牌有限责任公司 | 提供基本上类似于由薄荷醇提供的感觉的组合物 |
| PL1981465T3 (pl) | 2006-01-18 | 2016-03-31 | Intec Pharma Ltd | Metoda wytwarzania przyrządów do podawania środka przyjmowanego doustnie |
| CA2642479C (en) * | 2006-02-15 | 2014-08-19 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
| US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
| EP2117517B1 (en) * | 2007-01-11 | 2011-06-01 | XenoPort, Inc. | Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment |
| EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
| US20100137442A2 (en) * | 2008-02-01 | 2010-06-03 | Xenoport, Inc. | Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment |
-
2009
- 2009-10-19 JP JP2011539117A patent/JP2012510987A/ja active Pending
- 2009-10-19 EP EP09830077.5A patent/EP2378883B1/en not_active Not-in-force
- 2009-10-19 KR KR1020117014376A patent/KR20110116004A/ko not_active Withdrawn
- 2009-10-19 ES ES09830077.5T patent/ES2562925T3/es active Active
- 2009-10-19 CN CN200980153943.5A patent/CN102300463B/zh not_active Expired - Fee Related
- 2009-10-19 WO PCT/IB2009/007731 patent/WO2010064139A2/en not_active Ceased
- 2009-10-19 US US13/132,899 patent/US9693981B2/en not_active Expired - Fee Related
- 2009-10-19 CA CA2745741A patent/CA2745741A1/en not_active Abandoned
- 2009-10-19 WO PCT/IB2009/007419 patent/WO2010064100A1/en not_active Ceased
- 2009-10-19 PL PL09830077T patent/PL2378883T3/pl unknown
-
2010
- 2010-06-09 US US12/797,441 patent/US20110091542A1/en not_active Abandoned
-
2011
- 2011-06-05 IL IL213376A patent/IL213376A/en not_active IP Right Cessation
- 2011-06-22 ZA ZA2011/04620A patent/ZA201104620B/en unknown
-
2014
- 2014-11-14 JP JP2014231788A patent/JP6104873B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012510987A5 (OSRAM) | ||
| JP6104873B2 (ja) | ザレプロン胃内滞留性薬剤送達システム | |
| CN111405895B (zh) | 一种控释药物组合物及其制备方法 | |
| AU2008282900B2 (en) | Pulsatile gastric retentive dosage forms | |
| JP2015028094A5 (OSRAM) | ||
| RU2554740C2 (ru) | Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств | |
| Dehghan et al. | Gastroretentive drug delivery systems: A patent perspective | |
| JP5161071B2 (ja) | 胃酸分泌 | |
| JP2015154934A (ja) | カルビドパ／レボドパ胃内滞留性薬物供給 | |
| RU2008151949A (ru) | Фармацевтические лекарственные формы и композиции фенилэфрина для абсорбции в ободочной кишке | |
| Shashank et al. | Approaches to increase the gastric residence time: floating drug delivery systems-a review | |
| JP2018536007A5 (OSRAM) | ||
| JP2014240435A (ja) | 胃酸分泌を阻害するための組成物および方法 | |
| AU2009333300A1 (en) | Oral formulations | |
| EP3866758B1 (en) | Softgels with solid or gel-like polymeric fill matrix | |
| JP2008516893A (ja) | 多層錠剤および生体接着性剤形 | |
| CN104379138A (zh) | 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合 | |
| Rabadia et al. | The floating drug delivery system and its impact on calcium channel blocker: A review article | |
| JP2017511350A5 (OSRAM) | ||
| Jain et al. | An Insight on the Strategical Approach of Gastro-retentive Drug Delivery System | |
| Mansuri et al. | Glimpse of drug delivery systems for proton pump inhibitors | |
| JP5191121B2 (ja) | 溶解性を改善したジフェンヒドラミン含有医薬組成物 | |
| Benzine | Enzymatically triggered polymeric drug delivery systems for colon targeting | |
| JP2013006843A (ja) | 胃酸分泌 | |
| Thitinan | Development of multiple dose platforms for oral drug delivery |